NEW YORK ( TheStreet) -- CHANGE IN RATINGSApple ( AAPL) was initiated with a buy rating at Lazard. $540 price target. Company still has strong competitive advantages, Lazard Capital Markets said. Bona Film Group ( BONA) was downgraded to sell at TheStreet Ratings. Coleman Cable ( CCIX) was upgraded to buy at TheStreet Ratings. Carmike Cinemas ( CKEC) was upgraded to buy at TheStreet Ratings. VAALCO Energy ( EGY) was downgraded to hold at TheStreet Ratings. Embraer ( ERJ) was upgraded to buy at TheStreet Ratings. Meadowbrook Insurance Group ( MIG) was upgraded to buy at TheStreet Ratings. Microsoft ( MSFT) was downgraded from buy to neutral BofA/Merrill. $33 price target. Windows 8 lacks momentum, Bank of America/Merrill Lynch said. Panera Bread ( PNRA) was upgraded to buy at Goldman. $215 price target. Company also placed on the Conviction List. Company can continue to grow units and same-store sales, Goldman Sachs said. OMNOVA Solutions ( OMN) was downgraded to hold at TheStreet Ratings. Ocean Shore Holding ( OSHC) was downgraded to hold at TheStreet Ratings. Pharmacyclics ( PCYC) was downgraded to hold at TheStreet Ratings. Peoples Federal Bancshares ( PEOP) was upgraded to buy at TheStreet Ratings. Duke Energy ( DUK) was downgraded from buy to hold at Argus. Valuation call, as the stock has outperformed its peers year-to-date, Argus Research said. Brinker ( EAT) was upgraded to buy at Goldman. $44 price target. Company could see better domestic traffic growth, Goldman Sachs said.
PremierWest Bancorp ( PRWT) was upgraded to hold at TheStreet Ratings. Sykes Enterprises ( SYKE) was upgraded to buy at TheStreet Ratings. United Bancorp ( UBCP) was upgraded to buy at TheStreet Ratings. China Xiniya Fashion ( XNY) was upgraded to hold at TheStreet Ratings. Yelp ( YELP) was initiated as hold at TheStreet Ratings. Aruba Networks ( ARUN) was downgraded to neutral at UBS. Given multiple expansion and stock performance, the current valuation is fair, said UBS. Brown & Brown ( BRO) was upgraded from sell to neutral at Goldman. Company can continue to generate solid organic growth, Goldman Sachs said. $33 price target. Ulta Beauty ( ULTA) was upgraded to buy at Jefferies. $100 price target. Stock is attractive, following a 20% pullback, Jefferies said. Avista ( AVA) was downgraded to neutral at UBS based on valuation. Recent share price appreciation reflects recent successes in the rate case arena, said UBS. Centurylink ( CTL) was upgraded from neutral to overweight at JP Morgan. $38 price target. Had a positive meeting with management and feel better about the long-term business outlook, JP Morgan said. Finisar ( FNSR) was upgraded from neutral to buy at Lazard. $17 price target. Risk/reward is attractive at current levels, Lazard Capital Markets said.
STOCK COMMENTS/EPS CHANGES Acuity Brands ( AYI) price target was raised to $83 as the North American market is expected to show improving business trends in the second half of the year, said UBS. Bed Bath & Beyond ( BBBY) price target and earnings estimates were increased through 2014 at UBS. Q4 earnings will be in-line, but the online strategy will be the key to future success, said UBS. Price target goes to $64 Domino's Pizza ( DPZ) was removed from the conviction buy list, according to Goldman Sachs. Valuation call, based on a $60 price target.
LinkedIn ( LNKD) estimates, target were boosted at Morgan Stanley. Shares are now seen reaching $210, according to Morgan Stanley. Estimates also upped, given higher marketing solutions growth. Overweight rating. Nokia ( NOK) estimates, target were cut at Canaccord. Shares are now seen reaching $3.50, according to Canaccord Genuity. Estimates also reduced, as the company is likely losing market share to Samsung. Hold rating. Monsanto ( MON) price target and earnings estimates through 2014 were increased at Citi. Soybeans should drive growth starting in 2014 and the accelerated buyback is also a catalyst, said Citigroup. Price target goes to $122. Monsanto estimates, target raised at Piper as the company is carrying a lot of momentum into the planting season. Overweight rating. New York Community Bancorp ( NYCB) estimates were reduced at Citi through 2014 to reflect a soft quarter. Lower pre-payments and margins are expected and the anticipated accretive merger is unlikely to happen, said Citigroup. Thermo Fisher ( TMO) price target increased to $87 at UBS. Industry commentary has been positive, top line momentum remains intact and productivity and capital deployment will benefit the company, said UBS. Valent ( VRX) price target and estimates were reduced given the introduction of a generic version of Zovirax Ointment, said UBS. Price target goes to $81. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.